Life Sciences CIO priorities in the new reality

Digital leaders are facilitating increased adoption of digital and automation technologies to expedite delivery of value.

Paul Baguley

Paul Baguley

Principal, Advisory, KPMG US

+1 408-367-7608

Justin Hoss

Justin Hoss

National Technology Sector Leader, Life Sciences, KPMG US

+1 312-665-3265

Katie Dahler

Katie Dahler

Principal, National Life Sciences Leader, KPMG US

+1 973-912-6325

A Harvey Nash / KPMG CIO Survey 2020 industry report

Operational priorities, technology investments, business performance, cloud and data security, diversity and inclusion in Life Sciences

Historically, given the fundamental societal need for medicines regardless of economic conditions, the Life Sciences sector has been largely resistant to recessions—and has also generally been less severely impacted than other sectors by COVID-19. Indeed, in many ways the pandemic has put the industry into ‘surge’ mode. Companies are experiencing high demand for select products and have even been forced to discontinue some of their initiatives to focus on producing critical supply for COVID-19 management and treatment, and medical technologies that best position Life Sciences for the new reality. 

In this Life Sciences report, we share how being a digital leader differentiates you from your industry peers. We also compare survey results for Life Sciences to overall results in these key areas:

  • board priorities and investment 
  • strategy and operating model
  • delivering value at speed
  • people and culture
  • the rise of cyber
  • analytics and insight.
Key findings from the survey responses of 65 Life Sciences industry technology leaders

Full survey report

Now in its 22nd year, the Harvey Nash/KPMG CIO Survey is the largest IT leadership survey in the world, with over 4,200 responses from CIOs and technology executives across 83 countries in 2020.